Over the last 12 months, seven Arxis, Inc. the people running the company purchased shares at market prices, about $5.6 million in total, and none of them sold.
Roth Jason Aaron (Officer) made the biggest buy, worth around $1.7 million.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | Jankowski Ryan Anthony | Executive Officer | Buy | 4,464 | $28.00 | $125K | SEC |
| Apr 20, 2026 | Badakhsh Azad Sid | Officer | Buy | 36,000 | $28.00 | $1.0M | SEC |
| Apr 20, 2026 | Sealfon Ross Bradley | Officer | Buy | 12,500 | $28.00 | $350K | SEC |
| Apr 20, 2026 | Oetgen Stephen Duane | Director | Buy | 25,000 | $28.00 | $700K | SEC |
| Apr 20, 2026 | ALLEN PATRICK E | Director | Buy | 10,000 | $28.00 | $280K | SEC |
| Apr 20, 2026 | Perhamus Kevin Scott | Officer | Buy | 53,600 | $28.00 | $1.5M | SEC |
| Apr 20, 2026 | Roth Jason Aaron | Officer | Buy | 60,000 | $28.00 | $1.7M | SEC |
In the last 12 months Arxis, Inc. insiders made open-market purchases worth about $5.6 million and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in ARXS was filed on 2026-04-20.
No congressional trades in ARXS were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).